See Explanation
[]
Psychiatry
pharmacology
atypical antidepressants
A 62-year-old retired accountant, with a documented history of recurrent major depressive disorder, controlled asthma, and recently diagnosed moderate erectile dysfunction, attends a follow-up consultation in an outpatient general medical clinic. He reports persistent low mood, anhedonia, noticeable weight gain with increased appetite, and a lack of energy, impacting his daily activities over the past five months. He stopped a prior antidepressant, which he vaguely recalls as an SSRI, due to significant worsening of sexual function. Despite previously attempting smoking cessation without success, he expresses a strong desire to quit his 4 pack-year habit. His current lifestyle includes minimal physical activity. On examination, his BMI is 31 kg/m^2. His blood pressure is 138/86 mmHg, heart rate 78 bpm, respiratory rate 16 breaths/min, and temperature 36.9°C. Given his complex presentation, what is the most appropriate initial comprehensive management strategy for this patient, and what key adverse effects should be specifically monitored during the early phase of treatment?
| Lab Parameter | Value | Reference Range |
|---|---|---|
| White Blood Cell Count | 7.5 x 10^9/L | 4.0-11.0 x 10^9/L |
| Hemoglobin | 145 g/L | 130-170 g/L |
| Platelets | 280 x 10^9/L | 150-450 x 10^9/L |
| Sodium | 140 mmol/L | 135-145 mmol/L |
| Potassium | 4.1 mmol/L | 3.5-5.0 mmol/L |
| Chloride | 102 mmol/L | 98-107 mmol/L |
| Bicarbonate | 25 mmol/L | 22-29 mmol/L |
| Glucose (fasting) | 5.8 mmol/L | 3.9-6.1 mmol/L |
| Thyroid Stimulating Hormone (TSH) | 2.1 mIU/L | 0.4-4.0 mIU/L |
| Total Cholesterol | 5.5 mmol/L | <5.2 mmol/L |
| LDL Cholesterol | 3.2 mmol/L | <2.6 mmol/L |
| HDL Cholesterol | 1.1 mmol/L | >1.0 mmol/L |
| Triglycerides | 1.8 mmol/L | <1.7 mmol/L |
Edit question